Is Energy Transfer a Good Dividend Stock to Buy Now?
Energy Transfer (NYSE:ET) offers an impressive yield, to say the…
Sell
29
GPCR Quote, Financials, Valuation and Earnings
Last price:
$18.96
Seasonality move
:
13.43%
Day range:
$16.80 - $19.23
52-week range:
$13.22 - $62.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.26x
Volume:
1.3M
Avg. volume:
869K
1-year change:
-51.81%
Market cap:
$1.1B
Revenue:
--
EPS (TTM):
-$2.35
Earnings Data
Next earnings date for GPCR
May 09
2025
Most recent earnings per share
-$0.64
Missed by $0.47
(Feb 27/2025)
Consensus Estimate
-$0.17
(Feb 27/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GPCR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | -- | -- | -- | -$0.24 | -- |
| 05/09/2025 | Q1 | -- | -- | -- | -$0.23 | -- |
| 02/27/2025 | Q4 | -- | -- | -$0.64 | -$0.17 | -$0.47 |
| 11/13/2024 | Q3 | -- | -- | -$0.60 | -$0.19 | -$0.41 |
| 08/08/2024 | Q2 | -- | -- | -$0.54 | -$0.23 | -$0.32 |
| 05/09/2024 | Q1 | -- | -- | -$0.57 | -$0.22 | -$0.35 |
| 03/08/2024 | Q4 | -- | -- | -$0.48 | -$0.21 | -$0.27 |
| 11/17/2023 | Q3 | -- | -- | -$0.63 | -$0.22 | -$0.41 |
| 08/10/2023 | Q2 | -- | -- | -$0.60 | -$0.27 | -$0.33 |
| 05/11/2023 | Q1 | -- | -- | -$0.75 | -$0.37 | -$0.38 |
| 12/31/2022 | Q4 | -- | -- | -$0.31 | -$0.54 | $0.23 |
| 09/30/2022 | Q3 | -- | -- | -$0.49 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.61 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.51 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.61 | -- | -- |
Structure Therapeutics Earnings Questions
-
How Much did Structure Therapeutics Generate in Revenue Last Quarter?
Structure Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Structure Therapeutics Beat Earnings Last Quarter?
Structure Therapeutics announced earnings per share of -$0.64 which represents a miss of analyst forecast a -$0.17 per share.
-
Is Structure Therapeutics Profitable?
Structure Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Structure Therapeutics EPS Next Year?
Structure Therapeutics's earnings are forecast to decrease from -$2.34 per share to -$0.76 per share next year representing a decrease of -70.86%.
-
When is Structure Therapeutics's Earnings Date?
Structure Therapeutics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Did the Market Bottom Already?
The past few weeks have been among the most volatile…
Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
47
RGC alert for Apr 15
Regencell Bioscience Holdings [RGC] is down 11.8% over the past day.
Sell
50
SLP alert for Apr 15
Simulations Plus [SLP] is up 4.69% over the past day.
Sell
46
ZLAB alert for Apr 15
Zai Lab [ZLAB] is up 6.77% over the past day.
